Keep up to date with the key legal developments and trends.
Episode 9 of our patent licensing podcast from Meeting Room 7 focuses on the new Unified Patent Court (UPC) system in the EU.
Charlotte Tillett, head of Stevens & Bolton’s life sciences group, is joined by Senior Associate Tom Collins and Associate Kate Maguire to discuss the key considerations for both licensors and licensees in preparation for the UPC’s opening in June 2023. The episode includes:
- An overview of the UPC, the new Unitary Patent (UP), and the opt-out transitional period
- A discussion about the likely advantages and disadvantages of the new system
- Considerations for licensors, such as the risk of central patent revocation and exclusive licensees’ rights to independently commence proceedings before the UPC
- Considerations for licensees, such as opting-out, UP designation, UPC proceedings and consultation obligations